Oncology
ONCOLOGY Vol 39, Issue 10
Volume: 39
Issue: 10
ONCOLOGY Vol 39, Issue 9
Volume: 39
Issue: 9
ONCOLOGY Vol 39, Issue 8
Volume: 39
Issue: 8
ONCOLOGY Vol 39, Issue 7
Volume: 39
Issue: 7
ONCOLOGY Vol 39, Issue 6
Volume: 39
Issue: 6
ONCOLOGY Vol 39, Issue 5
Volume: 39
Issue: 5
ONCOLOGY Vol 39, Issue 4
Volume: 39
Issue: 4
ONCOLOGY Vol 39, Issue 3
Volume: 39
Issue: 3
ONCOLOGY Vol 39, Issue 2
Volume: 39
Issue: 2
ONCOLOGY Vol 39, Issue 1
Volume: 39
Issue: 1
ONCOLOGY Vol 38, Issue 12
Volume: 38
Issue: 12
ONCOLOGY Vol 38, Issue 11
Volume: 38
Issue: 11
ONCOLOGY Vol 38, Issue 10
Volume: 38
Issue: 10
ONCOLOGY Vol 38, Issue 9
Volume: 38
Issue: 9
ONCOLOGY Vol 38, Issue 8
Volume: 38
Issue: 8
ONCOLOGY Vol 38, Issue 7
Volume: 38
Issue: 7
ONCOLOGY Vol 38, Issue 6
Volume: 38
Issue: 6
ONCOLOGY Vol 38, Issue 5
Volume: 38
Issue: 5
ONCOLOGY Vol 38, Issue 4
Volume: 38
Issue: 4
ONCOLOGY Vol 38, Issue 3
Volume: 38
Issue: 3
ONCOLOGY Vol 38, Issue 2
Volume: 38
Issue: 2
ONCOLOGY Vol 38, Issue 1
Volume: 38
Issue: 1
ONCOLOGY Vol 37, Issue 12
Volume: 37
Issue: 12
ONCOLOGY Vol 37, Issue 11
Volume: 37
Issue: 11
ONCOLOGY Vol 37, Issue 10
Volume: 37
Issue: 10
ONCOLOGY Vol 37, Issue 9
Volume: 37
Issue: 9
ONCOLOGY Vol 37, Issue 8
Volume: 37
Issue: 8
ONCOLOGY Vol 37, Issue 7
Volume: 37
Issue: 7
ONCOLOGY Vol 37, Issue 6
Volume: 37
Issue: 6
ONCOLOGY Vol 37, Issue 5
Volume: 37
Issue: 5
Advertisement
Advertisement
Trending on CancerNetwork
1
ASH 2025: Key Anticipated Updates in the Leukemia Landscape
2
ASH 2025: Which Presentations Will Move the Multiple Myeloma Needle?
3
Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma
4
Fixed-Duration Venetoclax Combos Show Noninferior PFS to Ibrutinib in CLL
5
